Abstract

The aim of this study was to assess the diagnostic ability of transcranial sonography (TCS) for the evaluation of the medial temporal lobe (MTL) in Alzheimer’s disease (AD). Standard neuropsychological evaluation, TCS and 1.5 T MRI were performed for 20 patients with AD and for 20 age- and sex-matched healthy controls in a prospective manner. Measurements of the size of the third ventricle and heights of the MTL (A) and the choroidal fissure (B) were performed twice on each side by two independent neurosonologists for all participants. On MRI, both conventional and volumetric analyses of the third ventricle and hippocampus were performed. Receiver operating characteristic (ROC) curves analyses were applied. Height of the MTL on TCS had sensitivities of 73.7% (right)/63.2%(left) and specificities of 65% (right)/65–70% (left) Area under a curve (AUC) 75.4–77.2% (right), 60.4–67.8% (left)) for AD. A/B ratio on TCS had sensitivities of 73.7% (right)/57.9% (left) and specificities of 70.0% (right)/55.0% (left) (AUC 73.3% (right), 60.4% (left)) by the experienced neurosonologist, and sensitivities of 78.9% (right and left) and specificities of 60.0% (right)/65.0% (left) (AUC 77.8–80.0%) by the inexperienced neurosonologist for AD. On MRI, linear measurement of the hippocampus and parahippocampal gyrus height had sensitivities of 84.2% (right)/89.5% (left) and specificities of 80.0% (right)/85% (left) (AUC 86.1–92.9%) for AD. Hippocampal volume had sensitivities of 70% (right and left) and specificities of 75% (right)/80% (left) (AUC 77.5–78%) for AD. Atrophy of the right MTL in AD could be detected on TCS with a good diagnostic ability, however MRI performed better on the left.

Highlights

  • Alzheimer’s disease (AD) and other forms of dementia comprise the largest pool of all neurodegenerative disorders in Europe and in the world [1]

  • Keeping in mind that medial temporal lobe (MTL) atrophy is considered one of the hallmarks in AD [20], we aimed to evaluate the MTLs of AD patients comparing to healthy subjects using the structural ultrasound technique proposed by Yilmaz et al [19]

  • MTL atrophy could be detected on Transcranial B-mode sonography (TCS) with a good diagnostic ability on the right side but not on the left

Read more

Summary

Introduction

Alzheimer’s disease (AD) and other forms of dementia comprise the largest pool of all neurodegenerative disorders in Europe and in the world [1]. AD biomarkers, such as cerebrospinal fluid (CSF) amyloid β1-42, CSF tau, amyloid positron emission tomography (PET) imaging, fluorodeoxyglucose (18 F-FDG) PET imaging, volumetric magnetic resonance (MR) imaging, [2,3], a reliable, safe and affordable diagnostic test for the diagnosis of dementia is yet undiscovered. Using TCS, major parenchymal structures from the lower brainstem up to the parietal lobe, and the whole ventricular system may be visualized on standardized axial, coronal or semi-coronal imaging planes. Brain stem structures visualized by TCS include the substantia nigra, red nucleus, and midbrain nuclei raphe. Echogenicity of basal ganglia (thalamus, lenticular nucleus, head of caudate nucleus) and other deep brain structures (e.g., the middle temporal lobe, insula) may be assessed [5,6]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call